KUALA LUMPUR, Oct 10 (Bernama) — Crude palm oil (CPO) futures on Bursa Malaysia Derivatives are expected to turn bearish next week due to profit-taking activities. Interband Group of Companies senior palm oil trader Jim Teh said the bearish prices could help reduce Malaysia’s high palm oil stock levels ahead of the Malaysian Palm Oil Board’s (MPOB) September data release on Monday (Oct 12). “The trading range will be between RM4,200 to RM4,300 per tonne. This, in a way, will help to clear out some of our high stock positions,” he said. On physical demand, Teh said buyers were expected […]

Credit to: arminhamidian Forex Legion is a dynamic trading indicator designed to provide strong buy and sell signals, detailed market insights, and easy-to-understand visual cues for effective mark…

Bearish soybeans with stocks above expected  Ohio Ag Net

Investing.com -- Analysts at Citi and Bank of America are maintaining a cautious stance on Hims & Hers Health as competition in the GLP-1 space intensifies and growth begins to moderate. In a note Thursday, Citi flagged potential pressure from Evernorth’s newly announced benefit that caps patient out-of-pocket costs for GLP-1 drugs Wegovy and Zepbound at $200 per month, well below the $599 per month pricing offered through Hims’ new NovoCare partnership. “To the extent we see plan sponsors adopt this offering, we do think that this will be a slight headwind to HIMS’ newly announced NovoCare partnership,” Citi said. They noted that Evernorth’s model may also appeal to employers, as it could simplify access and help shift patient costs toward insurance. The bank kept its Sell rating and $30 per share target price for the stock. Bank of America echoed concerns about sustainability. They note that April data showed a 6% sequential decline in total sales and the second consecutive month of lower GLP-1 sales. “Revenue growth ex-GLP-1s has slowed significantly,” BofA wrote, citing increased ad focus on GLP-1 offerings, rising competition, and softer returns from long-duration subscriptions. The firm also warned that regulatory scrutiny on compounded semaglutide could cloud Hims’ FY25 outlook. “The ability to meet the FY25 guide hinges on the scale of personalized GLP-1s,” BofA wrote, noting that the upcoming end of the 503B compounding grace period could prompt FDA or Novo Nordisk (NYSE:NVO) action. BofA maintained an Underperform rating and $28 price target on HIMS.

(Reuters) -Tesla short sellers are up an estimated $11.5 billion for the year-to-date and positioning is bearish going into the electric vehicle maker’s quarterly results due after market close, according to the latest report from S3 Partners. Tesla (NASDAQ:TSLA) shares have tumbled 40% so far this year and analysts are expecting a weak report as January-March deliveries slid 13%, with market share losses to Chinese rivals, and brand damage stemming from CEO Elon Musk’s political work as part of the Trump administration. Investors who sell securities short borrow shares and then sell them, as they bet that the stock will fall so they can buy the shares back at the lower price in order to return them to the lender and pocket the difference. With a 10 million or 15% increase in shares sold short so far this year, S3 managing director Matthew Unterman writes that it is the most profitable short globally ahead of chip maker Nvidia (NASDAQ:NVDA), in which short sellers are up $9.4 billion. "With short interest climbing and sentiment deteriorating, Tesla’s post-earnings path hinges on results and guidance clarity," wrote Unterman. "A confirmed break above recent short interest resistance could suggest deepening bearish conviction, especially with analysts openly questioning leadership focus," he said. Wedbush analyst Dan Ives, traditionally a Tesla bull, said earlier this month that Musk should either "exit stage left" or step back from his political role in the U.S. Department of Government Efficiency (DOGE) and return his focus to Tesla. Tesla investors were also anxious ahead of the earnings report to know if the company’s plans to roll out a cheaper car and a robotaxi service this year are on track. After three straight days of losses, Tesla shares were up 6% at around $241 on Tuesday.

WhatsApp Group Invite

Bitcoin plunges below $75K before slight recovery. With resistance at $78.5K and $79.5K, BTC risks another fall toward the $70K floor amid bearish momentum.

Cardano (ADA) struggles below key resistance, risks dropping to $0.44 amid bearish pressure. Analysts eye double bottom for possible bullish reversal.

BTCUSDT respected the upper order flow block and grabbed liquidity and started the dump . then is grabbed another liquidity and is starting to dump again . current momentum is extremely bearish and this gives the possibility of a quick short scalp . Good LUck http://dlvr.it/TL0VgN

YouTube video by The Real Investment Show

H4 still bearish. Looking for downside momentum soon

Bearish XAUUSD is consolidating inside Triangle likely to breakdown